Abiopharma

🔍 Rutten Guillaume Marie Jean (Director)

Company: AMKOR TECHNOLOGY, INC. (AMKR)

Report Date: 2026-08-05

Detailed Transactions and Holdings:

• Sold 25,000 shares of Common Stock at $55.35 per share (Direct)
  Date: 2026-08-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 486,732.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 25,000 shares of Common Stock at $54.5 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 461,732.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.31 to $55.43. The Reporting Person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, Amkor Technology, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
• F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.48 to $54.62. The Reporting Person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.